StockData
Medline Inc. logo

Medline Inc.

MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3060% above fair value
$39.16+1.48 (+3.93%)

Close on Nov 18, 2026Market cap $51.48BP/E –Yield –

Medline Net Leverage Ratio by Quarter

Net Leverage Ratio (Net Debt / TTM Adjusted EBITDA) (×)

Medline Net Leverage Ratio: 2.50× in Q3 2026.

Latest, Q3 2026
2.50
Period ended Sep 30, 2026
Change on a year earlier
–
History
5 quarters
Since Q4 2024
Sources
4
Documents cited below

Where the Q3 2026 figure comes from

Source: SEC Form 8-K Ex. 99.1 Q3 2026 Earnings Release (2026-11-04) ↗

Reported in SEC Form 8-K Earnings Releases.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet Leverage Ratio (Net Debt / TTM Adjusted EBITDA) (×)Year on yearSource
Q3 2026Sep 30, 20262.50–SEC Form 8-K Ex. 99.1 Q3 2026 Earnings Release (2026-11-04) ↗
Q2 2026Jun 30, 20262.90–SEC Form 8-K Ex. 99.1 Q2 2026 Earnings Release (2026-08-05) ↗
Q1 2026Mar 31, 20263.10–SEC Form 8-K Ex. 99.1 Q1 2026 Earnings Release (2026-05-06) ↗
Q4 2025Dec 31, 20253.10-36.7%SEC Form 8-K Ex. 99.1 Q4 & FY2025 Earnings Release (2026-02-25) ↗
Q4 2024Dec 31, 20244.90–SEC Form 8-K Ex. 99.1 Q4 & FY2025 Earnings Release (2026-02-25) ↗

Breakdown

What makes up net Leverage Ratio

Cite this data

StockData. (2026). Medline Net Leverage Ratio (×), quarterly Q4 2024–Q3 2026 [Data set]. Compiled from Medline SEC filings and investor materials. https://stockdatahq.com/stocks/mdln/kpis/cap-net-leverage

See every metric in the Medline KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?